<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href='static/style.xsl' type='text/xsl'?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T10:12:09Z</responseDate><request verb="GetRecord" identifier="oai:ecommons.cornell.edu:1813/120913" metadataPrefix="dim">https://ecommons.cornell.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:ecommons.cornell.edu:1813/120913</identifier><datestamp>2026-05-15T17:53:13Z</datestamp><setSpec>com_1813_35</setSpec><setSpec>col_1813_47</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author">Xu, Jiashu</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="chair" lang="en_US">Lin, Hening</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">Baskin, Jeremy</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">Cerione, Richard</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2026-04-02T18:52:10Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2026-04-02T18:52:10Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2025-08</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Submission ID: 15018</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Publication ID: 32045050</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/1813/120913</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="doi">https://doi.org/10.7298/27r8-se64</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="bibid">17422669</dim:field>
   <dim:field mdschema="dc" element="description" lang="en_US">178 pages</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">ADP-ribosylation is a post-translational modification in which an ADP-ribose group from NAD+ is transferred to a substrate protein, releasing nicotinamide. This reaction is catalyzed by ADP-ribosyl transferases (ARTs), which are classified into mono-ADP-ribosyl transferases (mARTs) and poly-ADP-ribosyl transferases (pARTs), depending on the number of ADP-ribose units attached to the substrate. Poly-ADP-ribosyl transferases, such as PARP1, have been extensively studied in DNA repair and immune regulation, whereas mono-ADP-ribosyl transferases remain less understood. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-inducible poly(ADP-ribose) polymerase (TiPARP, also known as PARP7) is a mono-ADP-ribosyl transferase known to influence multiple biological pathways, though its mechanism is still poorly characterized. Notably, PARP7 is expressed at low levels under normal conditions due to self-ADP-ribosylation but is upregulated in response to cellular stress. This unique regulatory feature highlights PARP7 as a critical and challenging target for investigating its role in cellular processes. In my graduate study, I found that PARP7 independently down-regulates the type I interferon signaling pathway. Mechanistically, PARP7 ADP-ribosylates STAT1 and STAT2, two transcription factors involved in the type I interferon signaling pathway, and promotes ubiquitination of the two proteins. Then PARP7 recruits p62, which has a ubiquitin-binding domain (UBA), and sends STAT1/STAT2 to degradation through autophagy. In the physiological settings, Knockout and inhibition of PARP7 will significantly relieve the multiple sclerosis symptoms in C57BL/6 mice. In my second project, I found that various kinds of bacteria can transcriptionally upregulate PARP7 mRNA and protein levels. Autoinducer precursor, 4,5-dihydroxy-2,3-pentanedione (DPD), released by bacteria, induces PARP7 mRNA. PARP7 ADP-ribosylates and recruits HUWE1 to ubiquitinate V.cholerae or V.cholerae-containing compartments. Ubiquitinated proteins are recognized by p62 and autophagosome and V.cholerae will be eventually degraded through autophagy. PARP7 WT bone-marrow-derived macrophages (BMDM) clear out bacteria better compared to KO BMDM. We also noticed that PARP7 KO C57BL/6 mice have a higher density of V.cholerae compared to WT C57BL/6 mice, consistent with the cellular results.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">ADP-ribosylation</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Autophagy</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Bacterial Infection</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Multiple Sclerosis</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">STAT1</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">TiPARP</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">REGULATON OF TYPE I INTERFERON SIGNALING AND HOST DEFENSE AGANST BACTERIA BY 2,3,7,8-TETRACHLORODIBENZO-p-DIOXIN-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">dissertation or thesis</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline">Chemistry and Chemical Biology</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="grantor">Cornell University</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="level">Doctor of Philosophy</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="name">Ph. D., Chemistry and Chemical Biology</dim:field>
   <dim:field mdschema="dcterms" element="license">https://hdl.handle.net/1813/59810.2</dim:field>
   <dim:field mdschema="dspace" element="entity" qualifier="type">Publication</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="collection" authority="https://ecommons.cornell.edu/handle/1813/47" confidence="600">Cornell Theses and Dissertations</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="author">Xu, Jiashu</dim:field>
   <dim:field mdschema="cris" element="virtualsource" qualifier="collection">5893a6ea-7af3-41d7-abc6-04bcd26ab5df</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="cerif" element="openaire" authority="" confidence="-1">&lt;Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="9fd28980-00dd-46c3-b2bb-d0a04045954b">
	&lt;Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843&lt;/Type>
	&lt;Language>en&lt;/Language>
   	&lt;Title>REGULATON OF TYPE I INTERFERON SIGNALING AND HOST DEFENSE AGANST BACTERIA BY 2,3,7,8-TETRACHLORODIBENZO-p-DIOXIN-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE&lt;/Title>
   	&lt;PublishedIn>
    	&lt;Publication>
      	&lt;/Publication>
   	&lt;/PublishedIn>
   	&lt;PublicationDate>2025-08&lt;/PublicationDate>
   	&lt;DOI>https://doi.org/10.7298/27r8-se64&lt;/DOI>
   	&lt;Authors>
      	&lt;Author>
        	&lt;DisplayName>Xu, Jiashu&lt;/DisplayName>
         	&lt;Affiliation>
         		&lt;OrgUnit>
         		&lt;/OrgUnit>
         	&lt;/Affiliation>
      	&lt;/Author>
	&lt;/Authors>
   	&lt;Editors>
	&lt;/Editors>
    &lt;Publishers>
        &lt;Publisher>
            &lt;OrgUnit />
        &lt;/Publisher>
    &lt;/Publishers>
    &lt;Keyword>ADP-ribosylation&lt;/Keyword>
    &lt;Keyword>Autophagy&lt;/Keyword>
    &lt;Keyword>Bacterial Infection&lt;/Keyword>
    &lt;Keyword>Multiple Sclerosis&lt;/Keyword>
    &lt;Keyword>STAT1&lt;/Keyword>
    &lt;Keyword>TiPARP&lt;/Keyword>
   	&lt;Abstract>ADP-ribosylation is a post-translational modification in which an ADP-ribose group from NAD+ is transferred to a substrate protein, releasing nicotinamide. This reaction is catalyzed by ADP-ribosyl transferases (ARTs), which are classified into mono-ADP-ribosyl transferases (mARTs) and poly-ADP-ribosyl transferases (pARTs), depending on the number of ADP-ribose units attached to the substrate. Poly-ADP-ribosyl transferases, such as PARP1, have been extensively studied in DNA repair and immune regulation, whereas mono-ADP-ribosyl transferases remain less understood. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-inducible poly(ADP-ribose) polymerase (TiPARP, also known as PARP7) is a mono-ADP-ribosyl transferase known to influence multiple biological pathways, though its mechanism is still poorly characterized. Notably, PARP7 is expressed at low levels under normal conditions due to self-ADP-ribosylation but is upregulated in response to cellular stress. This unique regulatory feature highlights PARP7 as a critical and challenging target for investigating its role in cellular processes. In my graduate study, I found that PARP7 independently down-regulates the type I interferon signaling pathway. Mechanistically, PARP7 ADP-ribosylates STAT1 and STAT2, two transcription factors involved in the type I interferon signaling pathway, and promotes ubiquitination of the two proteins. Then PARP7 recruits p62, which has a ubiquitin-binding domain (UBA), and sends STAT1/STAT2 to degradation through autophagy. In the physiological settings, Knockout and inhibition of PARP7 will significantly relieve the multiple sclerosis symptoms in C57BL/6 mice. In my second project, I found that various kinds of bacteria can transcriptionally upregulate PARP7 mRNA and protein levels. Autoinducer precursor, 4,5-dihydroxy-2,3-pentanedione (DPD), released by bacteria, induces PARP7 mRNA. PARP7 ADP-ribosylates and recruits HUWE1 to ubiquitinate V.cholerae or V.cholerae-containing compartments. Ubiquitinated proteins are recognized by p62 and autophagosome and V.cholerae will be eventually degraded through autophagy. PARP7 WT bone-marrow-derived macrophages (BMDM) clear out bacteria better compared to KO BMDM. We also noticed that PARP7 KO C57BL/6 mice have a higher density of V.cholerae compared to WT C57BL/6 mice, consistent with the cellular results.&lt;/Abstract>
	&lt;Access xmlns="http://purl.org/coar/access_right" 
    >
    &lt;/Access>
&lt;/Publication>
</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>